TORONTO, ON / ACCESSWIRE / June 27, 2019 /Theralase® Technologies Inc. (“Theralase” or “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light activated Photo Dynamic Compounds (“PDC”) and their associated drug formulations intended to safely and effectively destroy various cancers, announced today that the Company has completed a successful Pre-Investigational New Drug (“IND”) meeting with the US Food and Drug Administration (“FDA”). In addition, Health Canada approved the amended Investigational Testing Application (“ITA”) for its Phase II Non-Muscle Invasive Bladder Cancer (“NMIBC”) clinical study (“Phase II Study”).

Pre-IND Meeting

The Company completed a Pre-IND meeting with the FDA and it was confirmed that the Company’s design of the Phase II ACT-NMIBC clinical study met FDA Guidance for Industry dated February 2018 on “BCG-Unresponsive Nonmuscle Invasive Bladder Cancer: Developing Drugs and Biologics for Treatment”. The guideline states that “In BCG-unresponsive NMIBC, a single-arm clinical trial with complete response rate and duration of response as the primary endpoint can provide primary evidence of effectiveness to support a marketing application.”1

Shawn Shirazi, Ph.D., CEO – Drug Division, Theralase stated that “We can now proceed with completing and filing an IND application with request for fast track designation, which pending approval, would allow the Company to expeditiously and effectively extend our clinical study into the US, to qualify and onboard clinical sites. In addition, the Company is continuing to qualify Canadian sites and working towards the European Medicines Agency approval, to qualify and onboard European clinical sites for a total of approximately 20 clinical sites.

Amended ITA

The amended ITA was submitted to Health Canada to update the current ITA, for an optimized design of the TLC-3200 medical laser system (“Study Device”).

The Study Device optimizations, include:

A more powerful laser engine (reduces patient treatment times)
Higher precision and repeatability in laser light detection (higher patient efficacy)
Increased robustness in laser power capacity and operator handling (higher patient safety)
Reduced physical size allowing for use of a flexible cystoscope (higher patient safety)
An ability to detect laser emitter movement during the Study Procedure (higher patient safety)
An optimized graphical user interface and system feedback control to allow the principal investigator to operate an “on-off” operation to deliver an effective Study II treatment

Kipton Lade, B.Sc, M.Sc. MBA, CEO – Device Division, Theralase stated that, “Approval of the amended ITA and CTA allows our clinical study sites to update their Research Ethics Board (“REB”) approvals to utilize the optimized Study Device. The optimized Study Device allows for shorter treatment times, increased efficacy and increased patient safety. We hope that these optimizations translate into a successful completion of the Phase II clinical study for the Company and potentially in the future allowing patient’s to be treated in a non-operating room environment.”

About Theralase® Technologies Inc.

Theralase® is a clinical stage pharmaceutical company dedicated to the research and development of light activated Photo Dynamic Compounds and their associated drug formulations intended to safely and effectively destroy various cancers.

1″BCG-Unresponsive Nonmuscle Invasive Bladder Cancer: Developing Drugs and Biologics for Treatment – Guidance for Industry” Dated: February 2018

Additional information is available at www.theralase.com and www.sedar.com

This news release contains “forward-looking statements” which reflect the current expectations of management of the Company’s future growth, results of operations, performance and business prospects and opportunities. Such statements include, but are not limited to, statements regarding the Company’s proposed development plans with respect to Photo Dynamic Compounds and their drug formulations. Wherever possible, words such as “may”, “would”, “could”, “should”, “will”, “anticipate”, “believe”, “plan”, “expect”, “intend”, “estimate”, “potential for” and similar expressions have been used to identify these forward-looking statements. These statements reflect management’s current beliefs with respect to future events and are based on information currently available to management. Forward-looking statements involve significant risks, uncertainties and assumptions including with respect to the ability of the Company to: adequately fund, secure the requisite regulatory approvals to commence and successfully complete a Phase II NMIBC clinical study in a timely fashion and implement its development plans. Many factors could cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements; including, without limitation, those listed in the filings made by the Company with the Canadian securities regulatory authorities (which may be viewed at www.sedar.com). Should one or more of these risks or uncertainties materialize or should assumptions underlying the forward looking statements prove incorrect, actual results, performance or achievements may vary materially from those expressed or implied by the forward-looking statements contained in this news release. These factors should be considered carefully and prospective investors should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in the press release are based upon what management currently believes to be reasonable assumptions, the Company cannot assure prospective investors that actual results, performance or achievements will be consistent with these forward-looking statements. The Company disclaims any intention or obligation to revise forward-looking statements whether as a result of new information, future developments or otherwise except as required by law. All forward-looking statements are expressly qualified in their entirety by this cautionary statement.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchanges) accepts responsibility for the adequacy or accuracy of this release.

For More Information:

1.866.THE.LASE (843-5273) x304
416.699.LASE (5273) x304
Amelia Tudo, Investor Relations Coordinator
atudo@theralase.com
www.theralase.com

SOURCE: Theralase Technologies Inc.

ReleaseID: 550186

Operating Income Jumps 90% Over Prior Fiscal Year

WESTMINSTER, MA / ACCESSWIRE / June 27, 2019 / TechPrecision Corporation (OTCQB: TPCS) (“TechPrecision” or “the Company”), an industry leading manufacturer of precision, large-scale fabricated and machined metal components and tested systems with customers in the defense, energy and precision industrial sectors, today reported financial results for the fourth quarter and the full year ended March 31, 2019. Net income was $0.5 million for the three months ended March 31, 2019 as compared to a net loss of $0.4 million in the same quarter a year ago. Net income was $1.1 million, or $0.04 per share, for the fiscal year ended March 31, 2019 compared with a net loss of $0.3 million, or $0.01 per share, for the prior fiscal year. Net sales for the fiscal 2019 fourth quarter and full year were $4.7 million and $16.7 million, respectively. Gross profit for the fourth quarter and full year of fiscal 2019 improved significantly over the same periods a year ago.

“This was another year of operational execution, resulting in a significant increase in net income,” stated Alexander Shen, TechPrecision’s Chief Executive Officer. “Our results benefited from efficient operational throughput and higher absorbed overhead as we managed a larger volume of manufacturing activity during the period. We expect to operate at or above current levels during the next fiscal year.”

The financial statements in this release for periods beginning after April 1, 2018 and all subsequent releases and reports reflect the adoption of the Accounting Standards Update (ASU) 2014-09, Revenue from Contracts with Customers (Topic 606), or ASC 606. Prior period amounts have not been restated and continue to be reported in accordance with the accounting standards in effect for those periods. (For more information regarding the adoption of ASC 606, refer to the Notes to the Consolidated Financial Statements in our Annual Report on Form 10K for the period ended March 31, 2019 filed with the Securities and Exchange Commission).

Fourth Quarter of Fiscal 2019 Financial Results

Net sales were $4.7 million, a slight increase when compared to the same quarter a year ago.
Gross profit was $1.5 million compared to $0.4 million in the same quarter last year, a significant increase, driven by a higher margin product mix and higher overhead absorption.
Operating income was $832,000 compared to operating loss of $393,000 in the same period a year ago.
Net income was $538,000, or $0.02 per diluted share, compared to net loss of $367,000, or $0.01 per diluted share, in the year-ago quarter.

Full Year Fiscal 2019 Financial Results

Net sales were $16.7 million, an 11% decrease when compared to the same period a year ago.
Gross profit was $4.6 million, a 15% increase compared to $4.0 million in the same period a year ago, primarily due to a higher margin product mix and higher overhead absorption.
Selling, general and administrative expenses were $2.7 million, or 9% lower than the same period a year ago.
Operating income was $1.8 million, compared to operating income of $1.0 million in the same period a year ago, a 90% increase.
Net income was $1.1 million compared to a net loss of $266,000 in fiscal 2018.
EBITDA was $2.6 million for the year ended March 31, 2019, compared to $1.7 million for the year ended March 31, 2018. Please refer to the reconciliation of EBITDA (a non-GAAP measure) to net income (a GAAP measure) in this release.

Financial Position

At March 31, 2019, TechPrecision had $2.0 million in cash. Fiscal 2019 was marked by an increase in customer project activity which resulted in more cash expended to ramp up production during the first half of the fiscal year. We expect that our available cash balance will begin to build again during the next operating quarter. Working capital was $6.3 million at March 31, 2019 compared to working capital of $4.9 million at March 31, 2018.

Income Taxes

For the year ended March 31, 2019, the Company recorded tax expense of $423,000. We did not make any significant tax payments for the year ended March 31, 2019, and do not expect to make any significant payments in Fiscal 2020, as we are able to utilize our federal net operating loss carryforward to offset taxable income. As of March 31, 2019, our federal net operating loss carryforward was approximately $8.3 million. U.S. tax laws limit the time during which these carryforwards may be applied against future taxes.

Teleconference Information

The Company will hold a conference call at 4:30 p.m. Eastern (U.S.) time on June 27, 2019. To participate in the live conference call, please dial 1-844-602-0380 five to 10 minutes prior to the scheduled conference call time. International callers should dial 1-862-298-0970. When prompted, reference TechPrecision.

A replay will be available until July 27, 2019. To access the replay, dial 1-877-481-4010 or 1-919-882-2331. When prompted, enter Conference Passcode 49531. The call will also be available live by webcast at TechPrecision Corporation’s website, www.techprecision.com, and will also be available over the Internet and accessible at: https://www.investornetwork.com/event/presentation/49531.

About TechPrecision Corporation

TechPrecision Corporation, through its wholly owned subsidiary, Ranor, Inc., manufactures large-scale, metal fabricated and machined precision components and equipment. These products are used in a variety of markets including: defense, aerospace, nuclear, industrial, and medical. TechPrecision’s goal is to be an end-to-end service provider to its customers by furnishing customized solutions for completed products requiring custom fabrication and machining, assembly, inspection and testing. To learn more about the Company, please visit the corporate website at http://www.techprecision.com. Information on the Company’s website or any other website does not constitute a part of this press release.

Safe Harbor Statement

This release contains certain “forward-looking statements” relating to the business of the Company and its subsidiary companies. All statements other than statements of current or historical fact contained in this release, including statements that express our intentions, plans, objectives, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions are forward-looking statements. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “predict,” “project,” “will,” “should,” “would” and similar expressions, as they relate to us, are intended to identify forward-looking statements. These statements are based on current expectations, estimates and projections made by management about our business, our industry and other conditions affecting our financial condition, results of operations or business prospects. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in, or implied by, the forward-looking statements due to numerous risks and uncertainties. Factors that could cause such outcomes and results to differ include, but are not limited to, risks and uncertainties arising from: our reliance on individual purchase orders, rather than long-term contracts, to generate revenue; our ability to change the composition of our revenues and effectively reduce operating expenses; the availability of appropriate financing facilities impacting our operations, financial condition and/or liquidity; our ability to receive contract awards through competitive bidding processes; our ability to maintain standards to enable us to manufacture products to exacting specifications; our ability to enter new markets for our services; our reliance on a small number of customers for a significant percentage of our business; competitive pressures in the markets we serve; changes in the availability or cost of raw materials and energy for our production facilities; operating in a single geographic location; restrictions in our ability to operate our business due to our outstanding indebtedness; government regulations and requirements; pricing and business development difficulties; changes in government spending on national defense; our ability to make acquisitions and successfully integrate those acquisitions with our business; general industry and market conditions and growth rates; general economic conditions; and those risks discussed in “Item 1A. Risk Factors” and elsewhere in the Company’s Annual Report on Form 10-K, as well as those described in any other filings which we make with the SEC.

Any forward-looking statements speak only as of the date on which they are made, and we undertake no obligation to publicly update or revise any forward-looking statements to reflect events or circumstances that may arise after the date of this release, except as required by applicable law. Investors should evaluate any statements made by us in light of these important factors.

Company Contact:

Mr. Thomas Sammons

Chief Financial Officer

TechPrecision Corporation

Phone: 978-883-5109

Email: sammonst@ranor.com

Investor Relations Contact:

Hayden IR
Brett Maas
Phone: 646-536-7331
Email: brett@haydenir.com
Website: www.haydenir.com

TECHPRECISION CORPORATION
CONSOLIDATED BALANCE SHEETS

March 31,

2019

March 31,

2018

ASSETS

Current assets:

Cash and cash equivalents

$
2,036,646

$
2,689,110

Accounts receivable, net

1,010,443

1,446,982

Contract assets

4,390,832

347,896

Inventories

1,240,315

2,088,485

Other current assets

498,059

450,540

Total current assets

9,176,295

7,023,013

Property, plant and equipment, net

4,860,609

5,202,448

Deferred income taxes

2,004,346

2,046,298

Other noncurrent assets, net

6,233

6,860

Total assets

$
16,047,483

$
14,278,619

LIABILITIES AND STOCKHOLDERS’ EQUITY:

Current liabilities:

Accounts payable

$
609,082

$
345,705

Accrued expenses

753,499

788,084

Contract liabilities

740,947

180,706

Current portion of long-term debt

822,105

766,354

Total current liabilities

2,925,633

2,080,849

Long-term debt, including capital leases

3,410,542

4,185,274

Stockholders’ Equity:

Common stock – par value $.0001 per share, 90,000,000 shares authorized,

29,234,594 and 28,824,593 shares issued and outstanding at March 31, 2019 and 2018

2,923

2,882

Additional paid in capital

8,693,106

8,561,995

Accumulated other comprehensive income

21,940

24,236

Retained earnings (accumulated deficit)

993,339

(576,617
)

Total stockholders’ equity

9,711,308

8,012,496

Total liabilities and stockholders’ equity

$
16,047,483

$
14,278,619

TECHPRECISION CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS

Three Months Ended

March 31,

Twelve Months Ended

March 31,

2019

2018

2019

2018

Net sales

$
4,712,154

$
4,668,420

$
16,702,558

$
18,729,994

Cost of sales

3,246,640

4,288,458

12,118,190

14,753,693

Gross profit

1,465,514

379,962

4,584,368

3,976,301

Selling, general and administrative

633,258

772,631

2,746,543

3,009,002

Income (loss) from operations

832,256

(392,669
)

1,837,825

967,299

Other income

32,428

2,634

41,033

4,267

Interest expense

(80,877
)

(98,931
)

(354,825
)

(412,988
)

Total other expense, net

(48,449
)

(96,297
)

(313,792
)

(408,721
)

Income (loss) before income taxes

783,807

(488,966
)

1,524,033

558,578

Income tax expense (benefit)

246,252

(121,761
)

423,357

824,486

Net income (loss)

$
537,555

$
(367,205
)

$
1,100,676

$
(265,908
)

Net income (loss) per share basic

$
0.02

$
(0.01
)

$
0.04

$
(0.01
)

Net income (loss) per share diluted

$
0.02

$
(0.01
)

$
0.04

$
(0.01
)

Weighted average number of shares outstanding basic

29,009,630

28,824,593

28,878,780

28,824,593

Weighted average number of shares outstanding diluted

30,666,447

28,824,593

30,293,670

28,824,593

TECHPRECISION CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS

Years Ended March 31,

2019

2018

CASH FLOWS FROM OPERATING ACTIVITIES

Net income (loss)

$
1,100,676

$
(265,908
)

Adjustments to reconcile net income (loss) to net cash provided by operating activities:

Depreciation

749,755

704,284

Amortization of debt issue costs

55,247

70,041

Loss on disposal of equipment

3,428

20,000

Stock based compensation expense

137,352

303,175

Change in contract loss provision

(143,105
)

52,197

Deferred income taxes

423,357

825,382

Changes in operating assets and liabilities:

Accounts receivable

436,539

75,794

Contract assets

(2,334,418
)

–

Inventories

(263,622
)

150,528

Other current assets

13,322

(28,443
)

Other noncurrent assets

(7,245
)

(17,742
)

Accounts payable

263,377

(19,603
)

Accrued expenses

246,501

(151,401
)

Contract liabilities

(149,855
)

(462,125
)

Net cash provided by operating activities

531,309

1,256,179

CASH FLOWS FROM INVESTING ACTIVITIES

Purchases of property, plant and equipment

(446,652
)

(994,530
)

Proceeds from disposition of equipment

35,309

80,000

Net cash used in investing activities

(411,343
)

(914,530
)

CASH FLOWS FROM FINANCING ACTIVITIES

Proceeds from exercise of stock options

182,400

–

Common stock repurchased

(188,600
)

–

Repayment of capital lease obligation

(14,002
)

(19,940
)

Repayment of long-term debt

(752,352
)

(697,536
)

Net cash used in financing activities

(772,554
)

(717,476
)

Effect of exchange rate on cash and cash equivalents

124

(1,219
)

Net decrease in cash and cash equivalents

(652,464
)

(377,046
)

Cash and cash equivalents, beginning of period

2,689,110

3,066,156

Cash and cash equivalents, end of period

$
2,036,646

$
2,689,110

TECHPRECISION CORPORATION
SUPPLEMENTAL INFORMATION
Reconciliation of EBITDA to Net Income (loss)

The following table provides a reconciliation of EBITDA to net income, the most directly comparable U.S. GAAP measure reported in our condensed consolidated financial statements:

(dollars in thousands)

March 31,

2019

March 31,

2018

Change

Amount

Net income (loss)

$
1,101

$
(266
)

$
1,367

Income tax expense

423

824

(401
)

Interest expense (1)

355

413

(58
)

Depreciation

750

704

46

EBITDA

$
2,629

$
1,675

$
954

(1) Includes amortization of debt issue costs.

SOURCE: TechPrecision Corporation

ReleaseID: 550035

FORT MYERS, FL / ACCESSWIRE / June 27, 2019 / NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, today announced that the company has entered into a new $250 million five-year Senior Secured Credit Agreement (the “New Credit Agreement”) consisting of a $100 million Revolving Credit Facility, a $100 million Initial Term Loan, and a $50 million Delayed Draw Term Loan (“DDTL”) which is available for 18 months. PNC Capital Markets LLC and PNC Bank, National Association acted as lead arranger and administrative agent on the transaction, respectively.

Upon closing on June 27, 2019, NeoGenomics received the Initial Term Loan Facility principal in full along with access to the Revolving Credit Facility and utilized $100 million of proceeds to retire NeoGenomics’ prior outstanding term loan and revolving credit facility. NeoGenomics expects to utilize the remaining borrowing capacity to support inorganic growth opportunities and for general corporate purposes.

“In combination with our May secondary equity offering, our new larger credit agreement provides NeoGenomics significant flexibility to opportunistically grow through M&A and invest in other key corporate initiatives,” said Sharon Virag, NeoGenomics’ Chief Financial Officer. “Our new credit agreement represents an attractive source of capital for NeoGenomics and we are very pleased with the strong support from our banking partners.”

About NeoGenomics, Inc.
NeoGenomics, Inc. specializes in cancer genetics testing and information services. The Company provides one of the most comprehensive oncology-focused testing menus in the world for physicians to help them diagnose and treat cancer. The Company’s Pharma Services division serves pharmaceutical clients in clinical trials and drug development.

Headquartered in Fort Myers, FL, NeoGenomics operates CAP accredited and CLIA certified laboratories in Ft. Myers and Tampa, Florida; Aliso Viejo, Carlsbad and Fresno California; Houston, Texas; Atlanta, Georgia; Nashville, Tennessee; Rolle, Switzerland, and Singapore. NeoGenomics serves the needs of pathologists, oncologists, academic centers, hospital systems, pharmaceutical firms, integrated service delivery networks, and managed care organizations throughout the United States, and pharmaceutical firms in Europe and Asia. For additional information about NeoGenomics, visit http://www.neogenomics.com/.

Forward Looking Statements
Certain information contained in this press release constitutes forward-looking statements for purposes of the safe harbor provisions of The Private Securities Litigation Reform Act of 1995, including the information set forth in the “Full-Year 2019 Financial Outlook”. These forward looking statements involve a number of risks and uncertainties that could cause actual future results to differ materially from those anticipated in the forward-looking statements as the result of the Company’s ability to continue gaining new customers, offer new types of tests, integrate its acquisition of the Genoptix business and otherwise implement its business plan, as well as additional factors discussed under the heading “Risk Factors” and elsewhere in the Company’s Annual Report on Form 10-K filed with the SEC on February 26, 2019, amended by a 10K/A filed with the SEC on May 8, 2019. As a result, this press release should be read in conjunction with the Company’s periodic filings with the SEC. In addition, it is the Company’s practice to make information about the Company available by posting copies of its Company Overview Presentation from time to time on the Investor Relations section of its website at http://ir.neogenomics.com/.

Forward-looking statements represent the Company’s estimates only as of the date such statements are made (unless another date is indicated) and should not be relied upon as representing the Company’s estimates as of any subsequent date. While the Company may elect to update forward-looking statements at some point in the future, it specifically disclaims any obligation to do so, even if its estimates change.

For further information, please contact:

NeoGenomics, Inc.
William Bonello
Chief Strategy and Corporate Development Officer
Director, Investor Relations
(239)690-4238 (w) (239)284-4314 (m)
bill.bonello@neogenomics.com

SOURCE: NeoGenomics, Inc.

ReleaseID: 550174

TORONTO, ON / ACCESSWIRE / June 27, 2019 / Rupert Resources Ltd (“Rupert” or the “Company”) (TSX-V: RUP; FSE: R05) announces that it has published its audited financial results for the twelve months ending February 28, 2019 and accompanying Managements Discussion and Analysis for the same period.

Both of the above have been posted on the Company’s website www.rupertresources.com and on Sedar at www.sedar.com.

During the 12 months ending February 28, 2019, the Company spent $6,579,680 (12 months ended February 28, 2018 – $7,494,051) on its exploration projects. As of February 28, 2019, Rupert held cash or cash equivalents of $5,949,381. The Company recorded a net loss and comprehensive loss for the year of $(6,171,061) (12 months ended February 28, 2018 – $(5,079,159)) and a net loss per share of $(0.05) (12 months ended February 28, 2018 – $(0.06)).

James Withall, Chief Executive Officer of Rupert Resources said, “We have made a number of breakthroughs at the Pahtavaara Project in 2019 culminating in the new discovery at Area 1 announced in May. Looking forward we now intend to focus our activities on identifying and developing a number of similar discoveries on our extensive land holding in northern Finland. We continue to be well supported by existing shareholders having raised over twelve million dollars in 2018 to fund the exploration programs.”

All references to currency in this press release are in Canadian dollars.

About Rupert

Rupert is a Canadian based gold exploration and development company that is listed on the TSX Venture Exchange under the symbol “RUP”. The Company owns the Pahtavaara gold mine, mill, and exploration permits and concessions located in the Central Lapland Greenstone Belt in Northern Finland (“Pahtavaara”). Pahtavaara has an Inferred mineral resource at a 1.5 g/t Au cut-off grade of 4.6 Mt at a grade of 3.2 g/t Au (474 koz) (see the technical report entitled “NI 43-101 Technical Report: Pahtavaara Project, Finland” with an effective date of April 16, 2018, prepared by Brian Wolfe, Principal Consultant, International Resource Solutions Pty Ltd., an independent qualified person under National Instrument 43-101 – Standards of Disclosure for Mineral Projects). The Company also holds a 100% interest in two properties in Central Finland – Hirsikangas and Osikonmaki; the Gold Centre property, which consists of mineral claims located in the Balmer Township, Red Lake, Ontario; and the Surf Inlet Property in British Columbia.

Technical Information

The technical information about the Company’s mineral properties contained in this release, other than information summarized or extracted from the Technical Reports, has been prepared under the supervision of Mike Sutton, PGeo, a non-executive Director of the Company and who is a “qualified person” within the meaning of NI 43-101. Mr. Sutton has reviewed the contents of this release and has consented to the inclusion in this release of all technical statements, other than information summarized or extracted from the Technical Report, in the form and context in which they appear and confirms that such information fairly represents the underlying data and study results.

For further information, please contact:

James Withall
Chief Executive Officer
jwithall@rupertresources.com

Thomas Credland
Head of Corporate Development & Investor Relations
tcredland@rupertresources.com

Rupert Resources Ltd
82 Richmond Street East, Suite 203, Toronto, Ontario M5C 1P1
Tel: +1 416-304-9004

Web: http://rupertresources.com/

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

The TSX Venture Exchange Inc. has in no way passed upon the merits of the proposed Transaction and has neither approved nor disapproved the contents of this press release.

Cautionary Note Regarding Forward Looking Statements

This press release contains statements which constitute “forward-looking statements”,including the completion of the proposed Transaction, deadlines, regulatory approvals, business activities and operating performance of the Company. The words “may”, “would”, “could”, “will”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect” and similar expressions, as they relate to the Company, are intended to identify such forward-looking statements. Investors are cautioned that forward-looking statements are based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made, and are inherently subject to a variety of risks and uncertainties and other known and unknown factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. These factors include the general risks of the mining industry, as well as those risk factors discussed or referred to in the Company’s annual Management’s Discussion and Analysis for the year ended February 28, 2018 available at www.sedar.com. Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. The Company does not intend, and does not assume any obligation, to update these forward-looking statements except as otherwise required by applicable law.

SOURCE: Rupert Resources Ltd

ReleaseID: 550178

BERLIN, GERMANY / ACCESSWIRE / June 27, 2019 / Market Logic today announced that it has been selected by Toyota Motor North America (TMNA) as the supplier of their new Consumer Insights Knowledge Management System. The top-selling automotive retail brand will power its insights engine with Natural Language Processing for search, collaboration features, video transcription and data integration.

TMNA chose Market Logic to achieve three objectives: to drive greater efficiency and effectiveness with their insights, to improve the consumer insights team and client working relationship, and to demonstrate the value of the Consumer Insights Team and drive greater visibility within TMNA, Toyota Motor Corporation and Toyota affiliates. What’s more, TMNA needed to find a supplier with proven experience with Knowledge Management Systems.

“We were looking for more than a software provider,” said Jon Ciarletta, TMNA Senior Consumer Insights Manager. “In addition to our essential requirements for functional performance, alignment with our branding and design aesthetic, and high security, we needed to work with a team that could act as a strategic advisor as we enter this next phase of data integration, efficiency and growth.”

Market Logic works with insights teams around the world, focusing efforts on creating a software experience that leverages consumer insights to drive growth in leading consumer brands. Market Logic CEO Kay Iversen said, “Toyota is at the cutting edge of the use of insights. As the first automotive company Market Logic is working with, we are excited to share our experiences to help Toyota to run an insights-driven business.”

ABOUT MARKET LOGIC

Market Logic helps the world’s best brands to run insights-driven businesses. We do this with insights portals to share and promote knowledge, intelligence portals to analyze markets and competitors, and market insights platforms to generate insights from data and inject these in business processes. Our software is used to drive customer centricity in CPG, healthcare, retail, finance & insurance, telecom, travel and media sectors, where our clients collaborate with 600 research agencies online. We employ 300+ software developers, data scientists and marketing professionals at regional headquarters in Berlin, Chicago, Pune and Singapore. For more information about Market Logic, see www.marketlogicsoftware.com.

ABOUT TOYOTA

Toyota has been a part of the cultural fabric in the U.S. and North America for more than 60 years, and is committed to advancing sustainable, next-generation mobility through our Toyota and Lexus brands. During that time, Toyota has created a tremendous value chain as our teams have contributed to world-class design, engineering, and assembly of more than 38 million cars and trucks in North America, where we operate 14 manufacturing plants (10 in the U.S.) and directly employ more than 47,000 people (over 36,000 in the U.S.). Our 1,800 North American dealerships (nearly 1,500 in the U.S.) sold 2.8 million cars and trucks (2.4 million in the U.S.) in 2018.

Through the Start Your Impossible campaign, Toyota highlights the way it partners with community, civic, academic and governmental organizations to address our society’s most pressing mobility challenges. We believe that when people are free to move, anything is possible. For more information about Toyota, visit www.toyotanewsroom.com.

Media Contact:

Elizabeth P. Morgan, CMO Market Logic
Phone: +49 178 749 2991
Email: epm@marketlogicsoftware.com

SOURCE: Market Logic Software

ReleaseID: 550131

Rapid Customer Acquisition, Collaboration with Visa® and Marqeta Support Accelerated Growth for Innovative Payment Solution Provider

ATLANTA, GA / ACCESSWIRE / June 27, 2019 / ConnexPay, a payment provider changing the way travel intermediaries do business, announced today that it has raised a Series A funding round of $7 million led by BIP Capital, one of the Southeast’s most active venture investors. ConnexPay works by seamlessly matching payments from travel buyers to travel suppliers in real-time. The technology reduces risk, eliminating the need for online travel agencies, tour operators, and consolidators to pre-fund payments or obtain lines of credit.

ConnexPay was named Most Innovative Startup in the travel industry at the Phocuswright conference in late 2018. The award exemplifies the value ConnexPay brings to travel companies. ConnexPay’s patent-pending technology is easily utilized by connecting to the company’s flexible APIs or accessing a PCI-certified portal. ConnexPay is leveraging Marqeta’s issuing technology as it scales throughout North America and eyes continued market expansion.

ConnexPay further announced that it is expanding the issuance of Visa® virtual cards in the travel industry. By collaborating with Visa’s issuing and acquiring financial institution partners, ConnexPay enables its customers to seamlessly use Visa single-use virtual credit cards to enable payments to travel suppliers.

“Collaborating with Visa to help expand issuance of Visa virtual cards provides a substantial boost to ConnexPay,” said Bob Kaufman, founder and CEO of ConnexPay. “Our intention is to be a game-changer for travel intermediaries and our successful funding round launches us one step closer to making this mission a reality.”

“Visa is at the forefront of innovation in payments globally. Our collaboration with ConnexPay reflects a strong desire to strengthen Visa’s position in the business-to-business travel vertical, and to do so alongside partners such as ConnexPay,” said Taira Hall, vice president, Visa Business Solutions.

Travel and tourism is one of the world’s largest economic sectors, supporting one in 10 jobs (319 million) worldwide and generating 10.4% (US $8.8 trillion) of world GDP, according to the World Travel & Tourism Council (WTTC). In the United States, the travel and tourism industry generated $1.62 trillion in 2018.

While ConnexPay is initially focused on the travel vertical, its technology also has applications for non-travel e-commerce intermediaries, such as marketplaces, event ticket brokerage, bill payment, and others. The growth capital provided by the Series A funding will be used by ConnexPay to further technology development, increase personnel, and expand into new markets.

“ConnexPay is transforming online payment acceptance and issuance for the travel industry,” said Mark Buffington, co-founder and CEO of BIP Capital. “ConnexPay reduces risk, lowers the cost of accepting cards, and enables unlimited credit and easier reconciliation. We’re pleased to work with the ConnexPay team to continue to accelerate the company’s growth.”

About ConnexPay

ConnexPay is a venture-backed innovative financial technology and payments company offering a combined merchant acquiring and virtual card issuing solution to mid-size corporations. The company’s technology reduces risk, resulting in lower cost of accepting cards, a unique way to access credit, and additional cash to invest in growth. ConnexPay is becoming the industry leader in payments for industries historically viewed as high risk to payment providers. For more information, visit www.connexpay.com or follow ConnexPay on LinkedIn or Twitter @ConnexPay. #simplyconnectingpayments

About BIP Capital

BIP Capital is recognized as one of the most active venture investors in the Southeast, serving entrepreneurs, investors, and operators to grow the emerging company ecosystem. It applies experience and process to make investment decisions and operational recommendations, allowing its portfolio companies to achieve and stay on a glide path of growth. Areas of focus include Enterprise SaaS, Healthcare IT, Digital Media, Dev Tools, and MarTech. For more information, visit www.bip-capital.com or follow BIP Capital on LinkedIn or Twitter @BIPCapital.

Media Contact:

Jacob Eisen, COO
612.601.0924
jeisen@connexpay.com

Additional Links:

ConnexPay Website
BIP Capital Website

Related Video:

SOURCE: ConnexPay

ReleaseID: 550171

VANCOUVER, BC / ACCESSWIRE / June 27, 2019 / DeepRock Minerals Limited (the “Company”) (CSE Symbol: “DEEP”), is pleased to announce the appointment of Mr. Richard Shatto to the position of President of the Company.

Richard Shatto has served the Company in the capacity of Operating Manager and as an important member of DeepRock Minerals’ Board of Directors, a position he will retain.

In his new position of President, Richard will be challenged by many an opportunity to excel in his core competencies. He is acknowledged as a highly respected senior level business management consultant with experience and expertise in a broad spectrum of corporate functions including: administration, finance, marketing, communications, branding, and sales.

Patrick D. O’Brien, CEO, Chairperson of DeepRock Minerals stated, “Since DeepRock Mineral’s IPO in late 2018, and until quite recently, Richard Shatto has certainly proven to be the star upon which the Company relied to remain afloat. Richard’s appointment to President is testament to how successful the Company’s Directors and shareholders alike feel Richard’s efforts have been. DeepRock Minerals has a very bright future ahead of it in the freshly unfolding Junior Mining Sector and Richard will play a very important role in all of the company’s future developments.”

Richard’s early education and career successes provided him a core competency for creative and corporate communications; including creative writing, conceptual branding, content creation, public and government relations communications, and social media. Richard studied Business and Marketing Communications at Biola University in La Mirada California. His education coupled with his vast experiences will prove invaluable to the future endeavours of DeepRock Minerals.

Over the past 15 years Richard has worked closely with senior management teams and Boards of Directors helping them visualize, develop, and implement business strategies that lead to increased revenues and sales, corporate growth and achievement of overall corporate success.

In recent years Richard has focussed his attention on start-ups and macro-companies and their specific challenges of developing concise visions upon which they can build the critical platforms for their corporate structure. Richard has guided several businesses, both Canadian and U.S., with their requirements for going public on the TSX venture exchange as well as the Canadian securities exchange, where in several cases he served as a director and/or senior officer in their C-suite.

Mr. Richard Shatto, as President commented, “I am very pleased to part of the management team of DeepRock Minerals as its President. I have worked toward this pinnacle for some time; and I am very pleased to join such an esteemed and highly experienced group on junior mining professionals. To be contributing to the success of DeepRock Minerals as it moves into the acquisition, exploration and development stages is very exciting ground for our company and its shareholders.”

About DeepRock Minerals Limited:

DeepRock Minerals is a highly dynamic Canadian mineral exploration company headquartered in Vancouver, British Columbia. DeepRock’s primary focus is in acquiring and developing prime North American exploration/development mining projects; as well as existing processing and producing mining operations of merit. DeepRock Minerals is managed by a very experienced and talented team of mining and business professionals with more than 150 years of combined extensive operating and financial experience and expertise. The shares of DeepRock Minerals trade on the Canadian Securities Exchange (CSE) under the trading symbol “DEEP”. Should you have any questions please feel free to contact the undersigned at PO@juniormining.com.

ON BEHALF OF THE BOARD OF DIRECTORS OF DEEPROCK MINERALS LIMITED

Patrick D. O’Brien, ICD.D, MIoD
Director, CEO
PO@juniormining.com

Cautionary Note Regarding Forward-Looking Statements:

Neither the Canadian Stock Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

This news release contains “forward-looking information” including statements with respect to the future exploration performance of the Company. This forward-looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements of the Company, expressed or implied by such forward-looking statements. These risks, as well as others, are disclosed within the Company’s filing on SEDAR, which investors are encouraged to review prior to any transaction involving the securities of the Company. Forward-looking information contained herein is provided as of the date of this news release and the Company disclaims any obligation, other than as required by law, to update any forward-looking information for any reason. There can be no assurance that forward-looking information will prove to be accurate and the reader is cautioned not to place undue reliance on such forward-looking information.

SOURCE: DeepRock Minerals Limited

ReleaseID: 550175

This Press Release Replaces The Previous Press Release Issued at 9:33 am EDT on June 27, 2019

GFTX Expecting to Drive Growth Through Innovation in the Textile Fiber Industry

SOMERSET, NJ / ACCESSWIRE / June 27, 2019 / Global Fiber Technologies (OTCQX: GFTX) operates three businesses that are involved in the distribution, rejuvenation and authentication of textile fibers.

Each business will draw on its patent pending technology and/or its trade secrets to give GFTX first mover advantage over its competition.

Our Three Businesses

1. Eco Tek 360, recovers and rejuvenates apparel utilizing patent pending technology which takes landfill destined corporate uniforms and repurposes them back to the same customer as high quality apparel for their employees. In the process we help our customers to reduce carbon footprints and collectively save billions of gallons of water. Eco Tek 360 is in the final stages of completing its development and anticipates commercial launch in 1st QTR. 2020

2. Fiber Chain, Inc., is creating a revolutionary block chain driven business platform for the efficient trading of textile fiber.

Fiber Chain will be able to reduce transaction times from weeks to minutes, eliminate the constant errors associated with processing transactions, evoke dramatic savings and simultaneously recording each transaction on a block chain for immutability.

Fiber Chain has completed approximately 70% of the total platform development. We are now moving toward completion of our BETA site anticipated to launch later in the year.

3. Authentic Heroes, Inc., specializes in developing handcrafted limited edition fanwear from original event worn apparel.

Our trade secrets and technology allow us to extract the original fibers from a game or event worn garment and make a limited series of collectible/wearable fanwear that is digitally encoded with the fibers from the original garment.

The authenticated garment receives an individual serial number and is marked with a QR code that leads the purchaser to his/her personal online vault.

While all three subsidiaries are driving innovation in their respective markets, we are focusing on the near-term revenue opportunity that Authentic Heroes represents.

We hope this gives our shareholders a bird’s eye view as to where we are with our “go to market” strategies and look forward to updating you soon.

Safe Harbor Act

Forward-Looking Statements: This release contains statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements appear in a number of places in this release and include all statements that are not statements of historical fact regarding the intent, belief or current expectations of Global Fiber Technologies, Inc., its directors or its officers with respect to, among other things: (i) financing plans; (ii) trends affecting its financial condition or results of operations; (iii) growth strategy and operating strategy. The words “may,” “would,” “will,” “expect,” “estimate,” “can,” “believe,” “potential” and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements including those relating to the Company’s financing being adequate for the Company to place its products in retail stores, execute its acquisition strategy, and to launch its growth and expansion plans, among others, are not guarantees of future performance and involve risks and uncertainties, many of which are beyond Global Fiber Technologies, Inc.’s ability to control, and actual results may differ materially from those projected in the forward-looking statements as a result of various factors. No information in this press release should be construed in any way whatsoever as an indication of Global Fiber Technologies Inc.’s future revenues, financial performance or stock price. More information about the potential factors that could affect the business and financial results is and will be included in Global Fiber Technologies, Inc., filings with the Securities and Exchange Commission at www.sec.gov.

SOURCE: Global Fiber Technologies

ReleaseID: 550173

SHANGHAI, CHINA / ACCESSWIRE / June 27, 2019 / 2019 Echemi Food Ingredient Sourcing Meeting & Food Industry Forum was held at Hall 4, NECC, Shanghai on June 20. David Zhang, the founder of Echemi, and industry experts from China, Pakistan, Canada, the United Kingdom and Indonesia were invited to share the development trend of the food industry. This meeting provided face-to-face communication opportunities for more than 30 global buyers of food ingredient industry and 100 Chinese suppliers, many of whom reached cooperation intention.

At 9:30 a.m., David Zhang firstly made an opening speech, showing the warmest welcome to all the distinguished guests. And then, he made an in-depth analysis of the food market.

(David Zhang was making the opening speech.)

“From 2014 to 2018, the food additives and ingredients industry has developed steadily. According to statistics, in the past five years, the variety output of major enterprises in the food additive industry has increased from 9.47 million tons to 12 million tons, with an average annual growth rate of 6.3%. Sales of main food additive products increased from 93.5 billion yuan to 116 billion yuan, with an average annual growth rate of 6.0%. In the same period, the export volume remained around 3.6 billion to 3.7 billion dollars.” David Zhang said on the opening ceremony.

Professor Steven Liu from Tunghai University delivered a speech entitled Trends of Natural
Preservative Developments and Application. In his speech, Professor Liu compared the food storage in ancient and modern time, and introduced innovative trend of food storage. Taking poly-lysine, nisin and natamycin as examples, Steven Liu pointed out that the current trend of preservatives should be “natural, healthy and scientific”.

(Professor Steven Liu was making a speech.)

Mr. Mohammad Fahim from Pakistan gave a detailed analysis about the Pakistani food ingredients market, including beverages, bakery, healthy food, and Halal. Also, Mr. Fahim shared some data about Sino-Pakistan import/export volume under the Belt and Road Initiative.

(Mr. Mohammad Fahim was making a speech.)

Mr. Fahim pointed out, “Over the past five years since the launch of CPEC, Pakistan’s GDP has grown by an average of 4.77%, and foreign direct investment in Pakistan has increased by about 240%. According to incomplete statistics, 17 projects in CPEC alone contribute $930 million in tax revenue to the Pakistani government.”

Dr. Liu Jian from Huiyang Biological Technology Co., Ltd., China. delivered a speech about the food ingredient, trehalose. From its discovery, features, functions, application and production, trehalose, a food material with high stability, was introduced in detail.

(Dr. Liu Jian was making a speech.)

And Mr. Anwar from Canada presented a speech entitled What we need from Chinese suppliers to Improve. In his speech, Mr. Anwar mentioned that Chinese chemical companies were now leading the world and had made great progress in production technology.

(Dr. Anwar was making a speech.)

Subsequently, Echemi invited three guests to participate in the interactive Q&A session. The host had in-depth discussions with Mr. Manzur from ACI, Bangladesh, Mr. Henri from Kanegrade, Finland and Ms. Vania from Indonesia on enterprise qualification, advantages and improvements of Chinese suppliers, prediction of future trend of food industry and online transaction. Mr. Henri noted, “China is a big producer of food raw materials. Eighty percent of the world’s vitamin C and xanthan gum are produced in China, so despite the long time of transportation, China is still the best choice for European importers.”

(Q&A session)

The sourcing meeting began in the afternoon. In three rounds of sourcing meeting, overseas buyers got information about suppliers, and suppliers also demonstrated their production and sales capabilities. At the meeting, global buyers of food ingredient industry held friendly exchanges with Chinese suppliers, many of whom reached cooperation intention.

2019 Echemi Food Ingredient Sourcing Meeting & Food Industry Forum gets a wonderful completion. As a leading part of chemical business in China and a professional B2B platform, Echemi aims to provide better products and services to global chemical companies In the future, Echemi will provide more personalized services for buyers and suppliers with various requests. There is a lot to look forward to.

Company Name: Echemi Group

Contact Person: Betha

Email: info@echemi.com

Phone: +86-0532-80905922 / 89072278

Address: 12F, HuaYin Mansion, No.5, Donghai West Road, Qingdao, China

City: Qingdao

Country: China

Website: https://www.echemi.com

SOURCE: Echemi Group

ReleaseID: 550158